Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website Xinhua Silk Road - Belt and Road Portal, China's silk road economic belt and 21st Century Maritime Silk Road Website
Subscribe CustomBlackClose

Belt & Road Weekly Subscription Form

download_pop

Research ReportCustomBlackClose

The full edition of the report is available at Xinhua Silk Road Database. You can click the “Table of Content” to have a general understanding of it.

Click on the button below to create your account and get immediate access to thousands of articles.

Start a Free Trial

Xinhua Silk Road Database
International Relation

China's Sinovac COVID-19 vaccine approved for emergency use in Nepal

June 07, 2021


Abstract : Nepal's drug regulator has approved the COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech for emergency use in the country, which is suffering from a deadly second wave of the pandemic.

A staff member displays a sample of the COVID-19 inactivated vaccine at a vaccine production plant of China National Pharmaceutical Group (Sinopharm) in Beijing, capital of China, April 10, 2020. (Xinhua/Zhang Yuwei)

KATHMANDU, June 5 (Xinhua) -- Nepal's drug regulator has approved the COVID-19 vaccine developed by Chinese pharmaceutical company Sinovac Biotech for emergency use in the country, which is suffering from a deadly second wave of the pandemic.

It is the second Chinese vaccine to have got approval from the Department of Drug Administration for emergency use in Nepal.

Nepal has already granted approval to the COVID-19 vaccine developed by China's Beijing Institute of Biological Products Co. Ltd, under Sinopharm, for emergency use in Nepal.

"It is to notify to all concerned that the conditional permission has been granted for emergency use authorization of COVDI-19 Vaccine (Vero Cell) Inactivated (CoronaVac) manufactured by Sinovac Life Sciences Co. Ltd in Nepal," said a statement issued by the department on Friday.

According to the department, the vaccine was approved for immunization of individuals aged 18 or above.

Bharat Bhattarai, director general of the department, told Xinhua on Saturday that the authorization was granted to Sinovac after the regulator completed the study of the data provided by the Chinese company.

A girl receives the first dose of COVID-19 vaccine at a hospital in Kathmandu, Nepal, on April 7, 2021. (Xinhua/Sulav Shrestha)

"It is also the last vaccine to get regulatory approval from the department. We have not received an application from any additional company for approval at the moment," said Bhattarai.

On June 1, the World Health Organization validated the Sinovac vaccine for emergency use for people 18 years and older.

In face of the raging coronavirus, Nepal has only got 2 percent of its some 30 million population administered twice for now as there is a short supply of vaccines, according to the Health Ministry.

As of Friday, the South Asian nation had recorded 581,560 confirmed COVID-19 infections and a death toll of 7,731. ■

Scan the QR code and push it to your mobile phone

Keyword: Nepal vaccine

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to [email protected] and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial

Ask Us A Question belt & road login close

If you have any questions, please enter them in the box below.

Identifying code Reload

Write to Us belt & road login close

Do you want to be a contributor to Xinhua Silk Road and tell us your Belt & Road story? Send your articles to silkroadweekly@xinhua.org and share your stories with more people.

Click on the button below to create your account and get im http://img.silkroad.news.cn/templates/silkroad/en2017te access to thousands of articles.

Start a Free Trial